Patent · US Expired

Antibodies against human CD40

US6312693A · kind A · utility

36Cited by
2References
26Claims
0Family size

Inventors

Key dates

Filing dateFeb 10, 1999
Grant dateNov 6, 2001
Priority date
Expiry dateFeb 10, 2019

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The Applicants have discovered humanized anti-human CD40 antibodies which block the interaction between gp39 and CD40. The anti-CD40 antibodies of the present invention are effective in modulating humoral immune responses against T cell-dependent antigens, collagen induced arthritis, and skin transplantation, and are also useful for their anti-inflammatory properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.